A case of follicular lymphoma associated with paraneoplastic cerebellar degeneration

Internal Medicine

Volumn 51, Issue 11, 2012, Pages 1387-1392

  Shimazu, Yayoi ^a   Minakawa, Eiko N ^a   Nishikori, Momoko ^a   Ihara, Masafumi ^a   Hashi, Yuichiro ^a   Matsuyama, Hirofumi ^a   Hishizawa, Masakatsu ^a   Yoshida, Sonoyo ^b   Kitano, Toshiyuki ^a   Kondo, Tadakazu ^a   Ishikawa, Takayuki ^a   Takahashi, Ryosuke ^a   Takaori Kondo, Akifumi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Takashima General Hospital   (Japan)

Author keywords

Follicular lymphoma; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological disorders

Indexed keywords

C REACTIVE PROTEIN; CD19 ANTIGEN; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; HLA DR ANTIGEN; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR; PREDNISOLONE; PROSTATE SPECIFIC ANTIGEN; RITUXIMAB;

ADULT; ARTICLE; ATAXIA; BONE MARROW EXAMINATION; CASE REPORT; CEREBELLUM ATROPHY; CERVICAL LYMPH NODE; COUGHING; DISEASE ASSOCIATION; DYSARTHRIA; FEVER; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; KARYOTYPING; LUNG LAVAGE; LUNG LESION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NYSTAGMUS; PARANEOPLASTIC NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; RECURRENT DISEASE; WHOLE BODY CT;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; PARANEOPLASTIC CEREBELLAR DEGENERATION; PREDNISONE; RECEPTORS, INTERLEUKIN-2; REMISSION INDUCTION; VINCRISTINE;

EID: 84863108980     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.7019     Document Type: Article

References (23)

1. Vedeler CA, Antoine JC, Giometto B, et al. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682-690, 2006.
2. Graus F, Dalmau J. Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol 20: 732-737, 2007.
3. Shams'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409-1418, 2003.
4. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66: 1717-1720, 2006.
5. Solal-Celigny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood 104: 1258-1265, 2004.
6. Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 27: 4555-4562, 2009.
7. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554, 2003.
8. Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75: 1135-1140, 2004.
9. Albert ML, Darnell RB. Paraneoplastic neurological degenerations: keys to tumour immunity. Nat Rev Cancer 4: 36-44, 2004.
10. Clouston PD, Saper CB, Arbizu T, et al. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42: 1944-1950, 1992.
11. Symonds RP, Hogg RB, Bone I. Paraneoplastic neurological syndromes associated with lymphomas. Leuk Lymphoma 15: 487-490, 1994.
12. Ang LC, Zochodne DW, Ebers GC, Kaufmann JC, Vinters HV. Severe cerebellar degeneration in a patient with T-cell lymphoma. Acta Neuropathol 69: 171-175, 1986.
13. Ishihara K, Suzuki Y, Shiota J, Kawamura M, Nakano I. An autopsied case of paraneoplastic neurologic syndrome (limbic encephalitis, cerebellar degeneration, and pseudohypertrophy in the inferior olivary nuclei) associated with T cell lymphoma. Rinsho Shinkeigaku 45: 583-589, 2005 (in Japanese, Abstract in English).
14. Rodis DG, Liatsos GD, Moulakakis A, Pirounaki M, Tasidou A.Paraneoplastic cerebellar degeneration: initial presentation in a patient with anaplastic T-cell lymphoma, associated with ichthyosiform cutaneous lesions. Leuk Lymphoma 50: 1369-1371, 2009.
15. Razzak A, Shields M, Allsup D. Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma. Leuk Lymphoma 48: 1456-1458, 2007.
16. Tanaka K, Yamazaki M, Sato S, Toyoshima I, Yamamoto A, Miyatake T. Antibodies to brain proteins in paraneoplastic cerebellar degeneration. Neurology 36: 1169-1172, 1986.
17. Hammack J, Kotanides H, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration. II. Clinical and immunologic findings in 21 patients with Hodgkin's disease. Neurology 42: 1938-1943, 1992.
18. Bernal F, Shams'ili S, Rojas I, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 60: 230-234, 2003.
19. Roberts WK, Darnell RB. Neuroimmunology of the paraneoplastic neurological degenerations. Curr Opin Immunol 16: 616-622, 2004.
20. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 7: 327-340, 2008.
21. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257: 509-517, 2010.
22. Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol 1: 294-305, 2002.
23. Shams'ili S, de Beukelaar J, Gratama JW, et al. An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253: 16-20, 2006.